Why join us? GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful...
Business Introduction At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our u...
Sr Director Market Access Strategy, Access Optimization Location: Philadelphia (preferred) or Durham, NC The Sr Director of GSK Market Access Strategy is a highly visible position within GSK US Market Access as well as Therapeutic Area ...
Southeast Region: GA, AL, MS, LA, SC, Charlotte and panhandle of FL ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, H...
Primary Geography: South Carolina ViiV Healthcare (VHC) is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highl...
This role sits within DP&I (Development Operations Platforms & Innovation), part of Development Global Clinical Operations at GSK. DP&I is building the capability to deploy AI at scale across clinical operations and the wider Development Op...
Region: Northern NJ ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV Healthcare is highly mission-driven in ...
This Director role supports the US Pipeline Oncology Director in leading US RWE & HO strategy and execution for Oncology pipeline assets. The role is accountable for developing and delivering components of the US data generation plan (inclu...
ViiV Healthcare is a global specialty HIV company, the only one that is 100% focused on researching and delivering new medicines for people living with, and at risk of, HIV. ViiV is highly mission-driven in our unrelenting commitment to be ...
Business Introduction: GSK remains committed to achieving bold commercial ambitions for the future. By 2031, we aim to deliver £40 billion in annual sales, leveraging our existing strong performance momentum to significantly increase our ...